Ratish Krishnan

Ratish Krishnan is a Senior Strategy Consultant in the Novel Modalities BioProcessing group for the Americas at MilliporeSigma.14 He is a Process Development Scientist with over 13 years of experience in vaccines, monoclonal antibodies, and viral vector modalities.25 Krishnan's expertise spans from pre-clinical to late-stage process characterization, validation, and commercialization activities, including BLA authoring.12

Prior to joining MilliporeSigma in 2019, Krishnan managed process development teams at leading companies such as Novartis and Pfizer.12 In his current role, he serves as a global subject matter expert for viral vector manufacturing and provides strategic guidance to internal stakeholders and key customers.2

Krishnan holds a master's degree in biotechnology from Pennsylvania State University.12 He is passionate about providing solutions to bring treatments to market and has presented scientific lectures at conferences and webinars.1 Additionally, he has made key contributions to peer-reviewed journals, articles, and white papers.1

In the field of gene therapy, Krishnan has been involved in discussions and research related to AAV (Adeno-Associated Virus) chromatography and empty-full capsid separation, which are crucial aspects of gene therapy manufacturing.2 He is committed to making a meaningful impact in the biotech industry and continues to share insights on platforms like LinkedIn about gene therapy and bioprocessing.36